Correlation Between Allakos and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allakos and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allakos and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allakos and Allogene Therapeutics, you can compare the effects of market volatilities on Allakos and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allakos with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allakos and Allogene Therapeutics.
Diversification Opportunities for Allakos and Allogene Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Allakos and Allogene is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Allakos and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Allakos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allakos are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Allakos i.e., Allakos and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Allakos and Allogene Therapeutics
Given the investment horizon of 90 days Allakos is expected to under-perform the Allogene Therapeutics. In addition to that, Allakos is 1.57 times more volatile than Allogene Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Allogene Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 240.00 in Allogene Therapeutics on September 4, 2024 and sell it today you would earn a total of 15.00 from holding Allogene Therapeutics or generate 6.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allakos vs. Allogene Therapeutics
Performance |
| Timeline |
| Allakos |
| Allogene Therapeutics |
Allakos and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allakos and Allogene Therapeutics
The main advantage of trading using opposite Allakos and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allakos position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Allakos vs. Apellis Pharmaceuticals | Allakos vs. Blueprint Medicines Corp | Allakos vs. Day One Biopharmaceuticals | Allakos vs. Atara Biotherapeutics |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |